The BSMO–Bordet Meeting 2026, featuring the 20th Belgian Symposium on the Integration of Molecular Biology Advances into Oncology Clinical Practice and the 12th Post-MASCC Seminar, will take place on November 20–21, 2026, at Steigenberger Icon Wiltcher’s in Brussels, Belgium.

The meeting will bring together oncologists, researchers, and healthcare professionals to discuss advances in molecular oncology and supportive cancer care.

Marking its 20th anniversary, the symposium will emphasize the translation of scientific discoveries into everyday oncology practice. Professor Awada will deliver a keynote lecture titled “20 Years of Oncology Innovation: Lessons & Future Directions,” reflecting on two decades of progress in cancer research and treatment while exploring opportunities for future clinical innovation.

The two-day meeting will provide a platform for scientific exchange and multidisciplinary collaboration, connecting developments in molecular biology with practical clinical applications. Alongside the Post-MASCC Seminar, the programme will encourage discussions on integrating advances in cancer treatment and supportive care into clinical practice to improve patient management and outcomes.